Brady Corporation delivered a solid start to fiscal 2026, underscored by organic revenue growth of 2.8% and adjusted EPS growth of 8% for the first quarter. The quarter benefited from meaningful contributions from acquisitions and currency, with total sales up 7.5%—organic growth of 2.8% complemented by 3.2% from acquisitions and 1.5% from foreign exchange. The company progressed on its strategic priorities, including a stronger emphasis on engineered products, a higher R&D cadence, and the expansion of its BradyScan connected-products ecosystem. Gross margin remained robust at 51.5%, aided by pricing actions and ongoing cost-reduction efforts, while SG&A control supported a stable operating margin in a challenging macro environment. Brady exited the quarter in a net cash position and maintained capital-allocation discipline (dividends growth for the 40th consecutive year, and a modest share repurchase program), providing flexibility to pursue organic growth and acquisitions. Management reiterated a disciplined view on the full-year revenue trajectory, guiding adjusted diluted EPS to $4.90–$5.15 and organic sales in the low single digits for the year ending July 31, 2026, with a notable tailwind potential from BradyScan and the Acquisitions pipeline, offset by tariff and FX headwinds.